Search Results
70 results found for "Alexander S Hauser"
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
., O'Brien, S. L., Stepniewski, T. K., Selent, J., Hill, S. J., & Calebiro, D. (2023). M., Kawakami, K., Masureel, M., Maeda, S., Garcia, K. C., von Zastrow, M., Inoue, A., & Kobilka, B. Reiter, E., Ahn, S., Shukla, A.K., and Lefkowitz, R.J. (2012).
- 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024
Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser
- Do You Believe AI Could Accelerate Drug Discovery?
This study examines these concerns by comparing AF2's predictions with experimental structures for docking This validates AF2's potential in enhancing drug discovery precision and efficiency.
- Odorant receptors – a bit of smell for drug discovery
express multiple ORs, tumor cells associated with the nervous system express a single OR gene type (Kalra S. Al 2017) and its activation promotes migration and angiogenesis (Kim S. et. al 2015). OR2AT4 activation leads to reduced proliferation and enhanced apoptosis of acute myeloid leukemia cells (S cells proliferation via activation by β-ionone which initiates prostate cancer cell cycle arrest (Jones S.
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser
- Feeder or trigger – CCR2 as a scavenger and regulator of cell migration
the responsiveness of canonical G protein–coupled chemokine receptors that bind to the same ligand(s) an example of a dual-function receptor that directly regulates both cell migration and scavenging (S. Grundmann et al. 2018), did not affect chemokine scavenging, consistent with prior work (S. Scavenging may allow cells to continuously migrate by remaining responsive to chemokines (S.
- GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
However, GRK3’s functions and clinical utility in GAC progression and metastases are unknown.
- Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin recept
Previously, we had identified a novel pyrazole-based agonist 1 ((S)-N-(1-(cyclobutylamino)-1-oxo-5-(piperidin
- New role of β-arrestins in MOR signaling
Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5391-3. doi: 10.1073/pnas.90.12.5391. Faouzi A, Varga BR, Majumdar S. Biased Opioid Ligands. Shiraki A, Shimizu S.
- Dr. GPCR University registration is now open! Secure your spot now!
includes congrats to: Clementine E Philibert and Mikel Garcia-Marcos for their work on Smooth operator(s) challenges Modulating Vertebrate Physiology by Genomic Fine-Tuning of GPCR Functions Smooth operator(s)
- What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024
Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser
- Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets
November 2021 "Nov. 15, 2021 LONDON – There’s not yet proof of the pudding, but Omass Therapeutics Ltd.’s
- All Aboard the GPCR Express: Your Weekly Update is here! Oct 14-20, 2024
Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser
- 📰 GPCR Weekly News, March 4 to 10, 2024
Stuart Maudsley, Nicole Perry-Hauser, Lauren Slosky, Cesare Orlandi, and Simone Prömel.
- Keratinocyte-derived defensins activate neutrophil-specific receptors Mrgpra2a/b to prevent skin...
Defensins and Mrgpra2 were critical for combating S. aureus infections and the formation of neutrophil
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser
- 📰 GPCR Weekly News, July 31 to August 6, 2023
Randy Hall's study: GPR37L1's role in shaping cortical astrocytes during development Dr. And Advance Novel Oral Small Molecule Medicines Targeting G Protein-Coupled Receptors Novo Nordisk A/S:
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser
- VAMP2: a crucial player in the delivery of MOR to the synapse
Jurado, S., D. Goswami, Y. Zhang, A.J.M. Molina, T.C. Südhof, and R.C. Malenka. 2013. Schoch, S., F. Deak, A. K ´ onigstorfer, M. Mozhayeva, Y. Sara, T.C. Südhof, and ¨ E.T.
- Anosmin 1 N-terminal domains modulate prokineticin receptor 2 activation by prokineticin 2
domain (WAP) is necessary for this modulatory activity, although data from GST pull-down (glutathione-S-transferase
- Neurocrine Biosciences Presents Data on Treatment of Adolescent Patients with Classic Congenital ...
These data will be shared as an oral presentation by Ron S.
- GPCR Buzz of the Week | Sep 23 - 29, 2024
HIGHLIGHT Research Associate - Professor Graeme Milligan HIGHLIGHT Postdoc in Molecular Pharmacology - The Hauser
- 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024
HIGHLIGHT Research Associate - Professor Graeme Milligan HIGHLIGHT Postdoc in Molecular Pharmacology - The Hauser
- Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin ...
through cAMP/protein kinase A signaling, consistent with AVPR2 coupling to the G protein subunit alpha s.
- Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells...
The results provide rationale for considering a combination(s) of FDA-approved SFK (dasatinib) and MEK
- ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser
- AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof
While AlphaFold2’s ability to predict static structures was groundbreaking, however, GPCRs are highly
- 📰 GPCR Weekly News, December 11 to 17, 2023
Nicole Perry-Hauser, on her selection as a 2024 Discovery Science Emerging Scholar at Vanderbilt University